merck & co., inc. - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,840 +0.84%

DJIA 48,336 +0.89%

Nasdaq 25,093 +0.80%

DAX 23,932 -0.13%

Gold $4,196 +0.16%

Oil $95.59 -1.13%

BTC $72,398 +1.44%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

S&P 500 6,840 +0.84%

DJIA 48,336 +0.89%

Nasdaq 25,093 +0.80%

DAX 23,932 -0.13%

Gold $4,196 +0.16%

Oil $95.59 -1.13%

BTC $72,398 +1.44%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

merck & co., inc.

Merck Terns Acquisition visualized with premium TERN-701 oncology drug concept

Pharma & Healthcare·Stocks·USA

Merck Terns Acquisition $6.7B Surge as Keytruda Cliff Nears

By Maik Kemper • Mar 25, 2026

Merck Terns Acquisition visualized with premium TERN-701 oncology drug concept

Pharma & Healthcare·Stocks·USA

Merck Terns Acquisition $6.7B Surge as Keytruda Cliff Nears

By Maik Kemper • Mar 25, 2026

Can the Merck Terns Acquisition really plug the looming Keytruda revenue gap or is $6.7 billion just a high-risk oncology bet? Maik Kemper Editor in…